NCT02975895View on ClinicalTrials.gov

Outcome of Different IOLs in Patients With and Without Uveitis

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

February 22, 2021

Study Completion Date

March 17, 2022

Conditions
UveitisCataractInflammationPosterior Capsule Opacification
Interventions
DEVICE

Hydrophobic IOL: Vivinex (HOYA)

Patients requiring cataract surgery will be randomized to one of the two types of IOLs.

DEVICE

Hydrophilic IOL: INCISE (Bausch+Lomb)

Patients requiring cataract surgery will be randomized to one of the two types of IOLs.

Trial Locations (1)

Unknown

Vastra Gotaland Region, Sahlgrenska University Hospital, Department of Ophthalmology, Mölndal

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT02975895 - Outcome of Different IOLs in Patients With and Without Uveitis | Biotech Hunter | Biotech Hunter